Answer
Breastfeeding should be discontinued throughout belzutifan treatment and for at least one week after the last dose.
Sources for this answer
- WELIREG 40 mg film-coated tabletsMerck Sharp & Dohme (UK) Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 9Document updated
Sources checked